Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03179891Phase 2Completed
A Phase 2 trial of libervant in epilepsy, sponsored by Aquestive Therapeutics. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03179891.